Cardiology

Doctors prescribing Praluent for their patients have two dosing options to choose from. Studies on the treatment option have shown that the safety profile for both are good for patients.

In just over a year, Praluent has shown benefits in helping patients lower their cholesterol level. Despite the progress, there have also been some challenges.

Researchers who evaluated adverse events in a large sample of patients taking NSAIDs for arthritis came to a surprising conclusion: celecoxib is the safest of three drugs studied.

Left ventricular assist devices are usually associated with keeping patients alive while they wait for a heart transplant. Using the devices with aggressive drug therapy enabled some patients to recover heart function and forgo the pumps.

One of the biggest challenges cardiologists face is treating patients with atrial fibrillation who are undergoing percutaneous coronary intervention, particularly when it comes to prescribing anticoagulants.

A new analysis of data from the Framingham Offspring Study indicated that the consumption of sugary beverages – but not diet beverages – is strongly associated with the progression of insulin resistance and the development of prediabetes.

An analysis of thousands of patients in Germany taken from a national registry found interventional procedures more dangerous than surgery for severe symptomatic aortic valve stenosis. But there may have been confounding factors.

With ever-growing data that the inflammation in rheumatic conditions can go hand-in-hand with cardiovascular inflammation, two different studies seek to broaden rheumatology’s approach to dangerous conditions it may influence.

For doctors concerned about cardiovascular disease in patients, there have been some lingering questions about the best medications to prescribe.

A study comparing whether certain heart patients did better with bilateral arterial grafts than single grafts had the surprising result of finding no benefit at five years.

Systemic atherosclerosis causes peripheral artery disease, and these patients are at risk of cardiovascular death and stroke.

AHA President Steven Houser opens the AHA Scientific Sessions 2016 with a moving talk on his father's premature death from heart disease.

Patients taken statins who survived heart attacks lived longer than those who did not take the drugs, a Taiwan research team found.

Certain types of inflammation go hand-in-hand. Columbia University researchers hypothesized that treatment that lowered arthritis disease activity would also decrease the risk of heart failure.

Using marijuana may double the risk of stress cardiomyopathy, researchers found.

The mysterious sudden deaths of apparently healthy people, some young and engaged in sports, could be explained by mutations uncovered by a Canada research team.

Being able to perform CPR matters a lot when it comes to saving children who experience a sudden out-of-hospital arrest.

The American Heart Association's Scientific Sessions 2016 gets underway in New Orleans, LA, this weekend. Here are some studies to watch for.

There are a lot of tasty things that people with diabetes should not eat. But butter is not one of them, a study found.

“Even though the treatment for stroke tPA improves recovery, some people who are eligible to receive the treatment are not getting it,” study author, Steven R. Messé, MD, explained.

Patients with a history of congestive heart failure were at increased risk of death during study trials of the drug, which is intended to fight recurring Clostridium difficile infections.

For many years, there were no good treatments for patients with pulmonary hypertension. That has changed recently, but there is still much more work to be done.

Unlike other conditions, pulmonary hypertension has symptoms that can be hard to identify in order to give the patients the right diagnosis. Misdiagnosis can not only worsen the symptoms, but also make treatment that much harder in the long run.

For cardiologists, treating a patient with hypertension is becoming a more common and less complicated effort. However, a similar condition, called pulmonary hypertension, is not nearly as well understood, managed, or treated.

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

In many hospitals there is a consistent effort to monitor how patients are responding to various treatments. This can be done at different increments which can determine in some cases how effective treatments are against pathogens which can affect a patients' health.

There are more and more challenges facing patients and doctors in hospital settings as "superbugs," or those conditions which are resistant to medications and antibiotics become a greater problem.

Authors of a new meta-analysis of warfarin use in ESRD patients raised concerns that the anticoagulant may not lower stroke risk in these patients, and as such, might itself be an unnecessary risk.

Phase 3 trials showed that empaglifloxin (Jardiance/Boehringer Ingelheim and Lilly) can reduce blood pressure in type 2 patients.

Several studies have ranked states by how fat its residents are. A new one looks at diabetes rates as well, and paints a picture of "diabesity" in the US.